The rapid development of artificial intelligence (AI) technologies in the context of the vast
amount of collectable data obtained from high-throughput sequencing has led to an …

High-throughput genomic analyses may improve outcomes in patients with advanced
cancers. MOSCATO 01 is a prospective clinical trial evaluating the clinical benefit of this …

Comprehensive genomic profiling using high-throughput sequencing brings a wealth of
information, and its place in the clinical setting has been increasingly prominent. This review …

Background High throughput molecular screening techniques allow the identification of
multiple molecular alterations, some of which are actionable and can be targeted by …

Background Molecular tumour boards (MTB) optimally match oncological therapies to
patients with genetic aberrations. Prostate cancer (PCa) is underrepresented in these MTB …

Background Human papillomavirus (HPV)-driven oropharyngeal cancer (OPC) patients are
characterised by a better prognosis than their HPV-negative counterparts. However, this …

Aim There is increasing use of molecular technologies to guide cancer treatments, but few
cost data are available. Our objective was to assess the costs of molecular-guided therapy …

Objectives Although high-throughput sequencing is revolutionising medicine, data on the
actual cost of whole exome sequencing (WES) applications are needed. We aimed at …

Résumé L'utilisation de biomarqueurs en oncologie permet de sélectionner des populations
pouvant bénéficier de traitements anticancéreux plus efficaces et moins toxiques, et …

Introduction: Tumor-based molecular profiling has increased in the area of precision
medicine. Their routine use is still limited by accessibility, cost and availability of tumor …